Zepp Health EBITDA Margin 2017-2025 | ZEPP
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Zepp Health (ZEPP) over the last 10 years. The current EBITDA margin for Zepp Health as of June 30, 2025 is .
| Zepp Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $0.20B | $-0.05B | -23.00% |
| 2025-03-31 | $0.18B | $-0.05B | -27.47% |
| 2024-12-31 | $0.18B | $-0.05B | -26.23% |
| 2024-09-30 | $0.21B | $-0.04B | -18.45% |
| 2024-06-30 | $0.25B | $-0.02B | -9.72% |
| 2024-03-31 | $0.30B | $-0.02B | -8.05% |
| 2023-12-31 | $0.35B | $-0.03B | -8.52% |
| 2023-09-30 | $0.42B | $-0.04B | -9.40% |
| 2023-06-30 | $0.50B | $-0.05B | -9.96% |
| 2023-03-31 | $0.58B | $-0.06B | -9.91% |
| 2022-12-31 | $0.60B | $-0.06B | -10.00% |
| 2022-09-30 | $0.70B | $-0.04B | -5.97% |
| 2022-06-30 | $0.71B | $-0.04B | -5.65% |
| 2022-03-31 | $0.89B | $-0.01B | -1.36% |
| 2021-09-30 | $1.10B | $0.03B | 2.28% |
| 2021-03-31 | $1.01B | $0.02B | 1.59% |
| 2020-12-31 | $0.99B | $0.03B | 2.74% |
| 2020-09-30 | $0.95B | $0.05B | 4.96% |
| 2020-06-30 | $0.88B | $0.07B | 7.50% |
| 2020-03-31 | $0.87B | $0.08B | 8.97% |
| 2019-12-31 | $0.84B | $0.09B | 10.42% |
| 2019-09-30 | $0.70B | $0.07B | 10.63% |
| 2019-06-30 | $0.59B | $0.06B | 10.32% |
| 2019-03-31 | $0.56B | $0.06B | 11.35% |
| 2018-12-31 | $0.53B | $0.05B | 9.83% |
| 2018-09-30 | $0.48B | $0.15B | 31.25% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.652B | $0.183B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.991B | 53.84 |
| Tempus AI (TEM) | United States | $13.179B | 0.00 |
| Doximity (DOCS) | United States | $12.725B | 56.62 |
| Hims & Hers Health (HIMS) | United States | $9.572B | 78.43 |
| IRhythm Technologies (IRTC) | United States | $5.461B | 0.00 |
| Hinge Health (HNGE) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $2.828B | 209.46 |
| Inspire Medical Systems (INSP) | United States | $2.771B | 40.74 |
| Heartflow (HTFL) | $2.557B | 0.00 | |
| Phreesia (PHR) | United States | $1.884B | 0.00 |
| Enovis (ENOV) | United States | $1.766B | 9.34 |
| 10x Genomics (TXG) | United States | $1.744B | 0.00 |
| Omnicell (OMCL) | United States | $1.497B | 28.84 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Clover Health Investments (CLOV) | United States | $1.343B | 0.00 |
| Claritev (CTEV) | United States | $1.135B | 0.00 |
| Evolent Health (EVH) | United States | $1.134B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.679B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.481B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.405B | 0.00 |
| Carlsmed (CARL) | United States | $0.354B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.53 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.239B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.234B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.213B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.175B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.168B | 0.00 |
| CareCloud (CCLD) | United States | $0.163B | 7.38 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.077B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.070B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |